Low Clinical Event Rates in Real-World Patients Receiving the XIENCE V (R) Everolimus-Eluting Stent (EES) Via Direct Stenting: One-Year Results From the XIENCE V USA Study
Publication
, Conference
Rutledge, DR; Hermiller, JB; Mao, V; Zhao, W; Pechonkina, AV; Wang, J; Jonnavithula, L; Simonton, CA; Krucoff, MW; Sudhir, K
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
September 21, 2010
Duke Scholars
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
EISSN
1558-3597
ISSN
0735-1097
Publication Date
September 21, 2010
Volume
56
Issue
13
Start / End Page
B60 / B60
Location
Washington, DC
Publisher
ELSEVIER SCIENCE INC
Conference Name
22nd Annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Rutledge, D. R., Hermiller, J. B., Mao, V., Zhao, W., Pechonkina, A. V., Wang, J., … Sudhir, K. (2010). Low Clinical Event Rates in Real-World Patients Receiving the XIENCE V (R) Everolimus-Eluting Stent (EES) Via Direct Stenting: One-Year Results From the XIENCE V USA Study. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 56, pp. B60–B60). Washington, DC: ELSEVIER SCIENCE INC.
Rutledge, David R., James B. Hermiller, Vivian Mao, Weiying Zhao, Alena V. Pechonkina, Jin Wang, Lalitha Jonnavithula, Charles A. Simonton, Mitchell W. Krucoff, and Krishnankutty Sudhir. “Low Clinical Event Rates in Real-World Patients Receiving the XIENCE V (R) Everolimus-Eluting Stent (EES) Via Direct Stenting: One-Year Results From the XIENCE V USA Study.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 56:B60–B60. ELSEVIER SCIENCE INC, 2010.
Rutledge DR, Hermiller JB, Mao V, Zhao W, Pechonkina AV, Wang J, et al. Low Clinical Event Rates in Real-World Patients Receiving the XIENCE V (R) Everolimus-Eluting Stent (EES) Via Direct Stenting: One-Year Results From the XIENCE V USA Study. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2010. p. B60–B60.
Rutledge, David R., et al. “Low Clinical Event Rates in Real-World Patients Receiving the XIENCE V (R) Everolimus-Eluting Stent (EES) Via Direct Stenting: One-Year Results From the XIENCE V USA Study.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 56, no. 13, ELSEVIER SCIENCE INC, 2010, pp. B60–B60.
Rutledge DR, Hermiller JB, Mao V, Zhao W, Pechonkina AV, Wang J, Jonnavithula L, Simonton CA, Krucoff MW, Sudhir K. Low Clinical Event Rates in Real-World Patients Receiving the XIENCE V (R) Everolimus-Eluting Stent (EES) Via Direct Stenting: One-Year Results From the XIENCE V USA Study. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2010. p. B60–B60.
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
EISSN
1558-3597
ISSN
0735-1097
Publication Date
September 21, 2010
Volume
56
Issue
13
Start / End Page
B60 / B60
Location
Washington, DC
Publisher
ELSEVIER SCIENCE INC
Conference Name
22nd Annual Transcatheter Cardiovascular Therapeutics (TCT) Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology